Fischer Medical Ventures Limited shares gained 3.21% to ₹734 in early trade today, adding ₹22.85 from the previous close of ₹711.15. The stock traded within the range of ₹728.00 to ₹739.95, with a market capitalization of ₹39.27 billion.
The surge follows the announcement that its wholly owned subsidiary, Time Medical International Ventures (India) Private Limited, has become the first indigenous MRI manufacturer in India to receive a CDSCO license for manufacturing and distributing Magnetic Resonance Diagnostic Devices (MRDD). This achievement marks a significant milestone for the Make in India initiative.
Approved MRI Systems
The license permits the manufacturing and distribution of the following advanced MRI systems:
- EMMA: 1.5T MRI Scanner
- PICA: 0.35T MRI Scanner
- MICA: 1.5T MRI Scanner
- QUIN: 1.5T MRI Scanner
These systems meet global safety and performance standards, with several models receiving FDA and CE approvals. The EMMA and PICA models have undergone clinical evaluation and comply with international regulatory guidelines.
Impact on Healthcare
The CDSCO license positions Time Medical to address the rising demand for advanced medical imaging in India. The 1.5T EMMA, MICA, and QUIN models offer high-resolution imaging for comprehensive diagnostics, while the PICA 0.35T model caters to specific clinical needs.
Fischer Medical Ventures emphasized its commitment to enhancing healthcare infrastructure in India by providing locally manufactured MRI systems that improve diagnostic capabilities and healthcare delivery nationwide.
Disclaimer: The information provided is for informational purposes only and should not be considered as financial or investment advice.
